• Login
    View Item 
    •   UTSW DSpace Home
    • UT Southwestern Electronic Theses and Dissertations
    • UT Southwestern Electronic Theses and Dissertations
    • View Item
    •   UTSW DSpace Home
    • UT Southwestern Electronic Theses and Dissertations
    • UT Southwestern Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    A Retrospective Cohort Study of Subacute Cutaneous Lupus Patients With and Without Systemic Lupus

    Thumbnail
    View/Open
    Available after 7/13/2013 (263.5Kb)
    Date
    2012-08-15
    Author
    Taylor, April
    Metadata
    Show full item record
    Abstract
    OBJECTIVE: To compare subacute cutaneous lupus erythematosus (SCLE) patients with systemic lupus erythematosus (SLE) (+SCLE/+SLE) versus SCLE patients without SLE (+SCLE/-SLE) over a period of five years. DESIGN: Retrospective cohort study. SETTING: Outpatient dermatology and rheumatology clinics at an academic medical center. PATIENTS: Forty-seven SCLE patients presenting between February 1989 and January 2012 were screened with nineteen meeting inclusion/exclusion criteria. PREDICTIVE VARIABLE: Anti-nuclear antibodies (ANA). RESULTS: Of the nineteen patients included, thirteen (68.4%) had SCLE only (+SCLE/-SLE) for the majority of the study period and six (31.6%) had both SCLE and SLE (+SCLE/+SLE). At baseline, +SCLE/+SLE patients were more likely to have a history of discoid lesions, oral ulcers, lupus non-specific findings, and require multiple medications. Over the five year study period, +SCLE/+SLE patients were also more likely to have ANA, immunologic disease (including anti-double-stranded DNA), renal disease, proteinuria, decreased complement, and to complain of arthralgias. Anti-Ro antibodies alone were more common in +SCLE/-SLE patients. CONCLUSIONS: Various cutaneous manifestations of lupus are present early in the course of SCLE, but laboratory values in +SCLE/+SLE become more distinct over time. Thus, the aforementioned variables should be tested for evidence of disease involvement and to ensure adequate treatment among +SCLE/+SLE patients. In contrast, +SCLE/-SLE patients may be tested for the development of anti-Ro antibodies but need not be monitored for the other laboratory abnormalities, given their rarity among patients with SCLE only. Larger prospective studies comparing disease course in SCLE patients with and without SLE are needed to verify these findings.
    URI
    http://hdl.handle.net/2152.5/1117
    Collections
    • UT Southwestern Electronic Theses and Dissertations

    UT Southwestern Health Sciences Digital Library and Learning Center | 5323 Harry Hines Boulevard, Dallas, Texas 75390-9049
    Telephone 214-648-2001 | Email
    Library Home | UT Southwestern Home
    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    TDL
    Theme by 
    Atmire NV
     

     

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    UT Southwestern Health Sciences Digital Library and Learning Center | 5323 Harry Hines Boulevard, Dallas, Texas 75390-9049
    Telephone 214-648-2001 | Email
    Library Home | UT Southwestern Home
    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    TDL
    Theme by 
    Atmire NV